Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin/Hypocretin Signaling
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

The Neurochemistry of Autism
Rosa Marotta, Maria Cristina Risoleo, Giovanni Messina, et al.
Brain Sciences (2020) Vol. 10, Iss. 3, pp. 163-163
Open Access | Times Cited: 230
Layer- and Cell Type-Specific Modulation of Excitatory Neuronal Activity in the Neocortex
Gabriele Radnikow, Dirk Feldmeyer
Frontiers in Neuroanatomy (2018) Vol. 12
Open Access | Times Cited: 164
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
Tao Xue, Xin Wu, Shujun Chen, et al.
Sleep Medicine Reviews (2021) Vol. 61, pp. 101573-101573
Closed Access | Times Cited: 68
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 63
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice
Fang Zhou, Xudong Yan, Chun Wang, et al.
Neurobiology of Aging (2020) Vol. 91, pp. 66-75
Closed Access | Times Cited: 50
Synthesis and Characterization of a New Carbon-11 Labeled Positron Emission Tomography Radiotracer for Orexin 2 Receptors Neuroimaging
Yanli Wang, Yongle Wang, Yan Liu, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 215-222
Open Access | Times Cited: 6
Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
Meifang Liu, Yan Xue, Cui Liu, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 55
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Laurine Becquet, Catalina Abad, Mathilde Leclercq, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 42
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis
Mengzhen Zhou, Jiyou Tang, Shasha Li, et al.
Frontiers in Human Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states
Allison K. Graebner, Manasi Iyer, Matthew E. Carter
Frontiers in Systems Neuroscience (2015) Vol. 9
Open Access | Times Cited: 37
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35
Neuropeptides in Cancer: Friend and Foe?
Yue Wu, Adrian Berisha, Jeremy C. Borniger
Advanced Biology (2022) Vol. 6, Iss. 9
Closed Access | Times Cited: 16
Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats
Cui Liu, Yan Xue, Meifang Liu, et al.
Journal of Neurochemistry (2018) Vol. 147, Iss. 3, pp. 380-394
Open Access | Times Cited: 28
Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25
Orexins, Sleep, and Blood Pressure
Mariusz Siemiński, Jacek Szypenbejl, Eemil Partinen
Current Hypertension Reports (2018) Vol. 20, Iss. 9
Open Access | Times Cited: 25
Behavioral Neuroscience of Orexin/Hypocretin
Andrew J. Lawrence, Luı́s de Lecea
Current topics in behavioral neurosciences (2017)
Open Access | Times Cited: 24
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 44, pp. 7582-7596
Open Access | Times Cited: 16
Hypocretin/orexin system in the nucleus accumbens as a promising player in the extinction and reinstatement of methamphetamine-induced CPP
Haleh Amirteymori, Saeideh Karimi‐Haghighi, Mahboobeh Mirmohammadi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110616-110616
Closed Access | Times Cited: 11
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Alain Couvineau, Nicole Pascal, Gratio Valérie, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4849-4849
Open Access | Times Cited: 15
Narcolepsy—A Neuropathological Obscure Sleep Disorder: A Narrative Review of Current Literature
Vishal Chavda, Bipin Chaurasia, Giuseppe Emmanuele Umana, et al.
Brain Sciences (2022) Vol. 12, Iss. 11, pp. 1473-1473
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top